Found 75 matching trials
Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy PHASE2 The purpose of this trial is to compare the efficacy and safety of Inotuzum...
Show More Location
Stoke Mandeville Hospital (including Wycombe Hospital)
Learn More & Join Trial
Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse PHASE1 The purpose of this study is to determine the recommended dose of CMC544 ad...
Show More Learn More & Join Trial
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL PHASE1 In the proposed study, escalating doses of inotuzumab ozogamicin will be ad...
Show More Location
Vanderbilt-Ingram Cancer Center
Learn More & Join Trial
Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL PHASE2 To study the minimal residual disease (MRD) clearance rate of olverembatini...
Show More Location
Multiple Locations
Learn More & Join Trial
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma PHASE2 This is a Phase II clinical trial testing the use of two antigen-directed t...
Show More Location
Novant Health Presbyterian Hemby Children's Hospital
Learn More & Join Trial
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia PHASE3 ALLTogether collects the experience of previously successful treatment of i...
Show More Location
L'hôpital Universitaire des enfants Reine Fabiola (Huderf)
Learn More & Join Trial
Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma PHASE1 To determine the Maximum Tolerated Dose (MTD), the tolerability, and the in...
Show More Location
UAB CCC Clinical Studies Unit
Learn More & Join Trial
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL PHASE2 In the treatment of Ph-negative (Ph-) B-cell acute lymphoblastic leukemia (...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML PHASE1 This phase I/II trial studies the side effects and best dose of bosutinib w...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia PHASE2 This phase II trial studies how well levocarnitine and vitamin B complex wo...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial